logo
Select company
Select metric
Ticker Information

Ticker

TXMD

Company Name

THERAPEUTICSMD INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

THERAPEUTICSMD INC - Enterprise Value over Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TXMD - EV/FCF Historical data
DateEnterprise ValueEnterprise Value over Free Cash FlowFree Cash Flow
6/30/2025$ 12.44M0$ -243K
3/31/2025$ 17.81M37.18$ 479K
12/31/2024$ 12.64M17.26$ 732K
9/30/2024$ 18.03M0$ -7.12M
6/30/2024$ 20.03M0$ -9.39M
3/31/2024$ 25.39M0$ -14.73M
12/31/2023$ 28.61M0$ -48.14M
9/30/2023$ 17.83M0.91$ 19.49M
6/30/2023$ 33.92M11.21$ 3.03M
3/31/2023$ 34.94M0$ -7.68M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Enterprise Value over Free Cash Flow

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
EV / FCF
(=) EV/FCF
EV/FCF for THERAPEUTICSMD INC is calculated as follows: EV [ $ 581M ] / FCF [ $ -180.35M ]
(=) EV/FCF [ 0 ]

TXMD - Enterprise Value over Free Cash Flow, Last 5 years

0.91

Minimum

Sep 30, 2023

37.18

Maximum

Mar 31, 2025

16.64

Average

14.23

Median

EV/FCF Benchmark Analysis

The chart above depicts the distribution of EV/FCF for companies in the Total Stock Market. The average EV/FCF of the companies is 23.48 with a standard deviation of 16.17.
The following table provides additional summary stats:
EV/FCF in the Market:
filtered constituents2.2K
min0.05
max78.21
average23.48
median19.11
std16.17